Goldman CEO Solomon Sees Vaccine Bringing Staff Back by End of Year

The transcript discusses the slow vaccine rollout and its impact on plans, highlighting the need for efficient distribution. It mentions the growing vaccine supply and the potential role of the private sector in distribution. The speaker is optimistic about returning Goldman Sachs employees to work by year-end but acknowledges ongoing economic challenges due to the pandemic.

What concerns have been raised regarding the vaccine rollout?

How is the uncertainty surrounding the vaccine supply affecting planning for businesses?

What measures are suggested to improve the distribution of the vaccine?

What is the expected timeline for bringing employees back to Goldman Sachs?

What economic challenges are anticipated following the pandemic shutdowns?